Calling For Patients: Ampligen Study Is Still Recruiting
Hunter-Hopkins Center is one of two sites in the USA currently participating in an open label study of Ampligen. Persons with CFS may qualify to receive Ampligen therapy. Details are available on the US government Clinical Trials website at: http://www.clinicaltrials.gov/ct2/show/NCT00215813?term=00215813&rank=1
The Hunter-Hopkins program is described at https://drlapp.com/research/ click on the Ampligen tab.
If you are interested in joining the Ampligen Study or you have more questions, contact Wendy Fallick (Research Coordinator) or Dr. Black at Hunter-Hopkins.